Glaxosmithkline Pharmaceuticals

Rediff.com » News » Glaxosmithkline Pharmaceuticals

News for Glaxosmithkline Pharmaceuticals

Business

How life has changed for India's pharma salesforce

Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and......

GSK withdraws sale of Zinetac after health alert

GSK is continuing with investigations into the potential source of the NDMA, which is a known environmental contaminant and found in water and foods, including meats, dairy products, and......

This is why Godrej is a big name in India's real estate sector

In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year After a triple blow from note ban, the new tax regime and the implementation of......

Q4 earnings, inflation data to drive stocks this week: Experts

Fourth quarter earnings of blue-chips such as Infosys, TCS, Wipro, RIL and inflation data for March will dictate the trend on the bourses in a holiday-shortened week ahead, experts said. Stock......

Big Pharma still betting on 'messed up' Indian drugs market

Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the......

Rediff News

Glaxosmithkline Pharmaceuticals

News for Glaxosmithkline Pharmaceuticals

How life has changed for India's pharma salesforce

GSK withdraws sale of Zinetac after health alert

This is why Godrej is a big name in India's real estate sector

Q4 earnings, inflation data to drive stocks this week: Experts

Big Pharma still betting on 'messed up' Indian drugs market

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS